Mereo BioPharma (MREO) Retained Earnings (2020 - 2025)
Historic Retained Earnings for Mereo BioPharma (MREO) over the last 6 years, with Q3 2025 value amounting to -$493.7 million.
- Mereo BioPharma's Retained Earnings fell 830.63% to -$493.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$493.7 million, marking a year-over-year decrease of 830.63%. This contributed to the annual value of -$462.9 million for FY2024, which is 1030.74% down from last year.
- Mereo BioPharma's Retained Earnings amounted to -$493.7 million in Q3 2025, which was down 830.63% from -$486.6 million recorded in Q2 2025.
- Mereo BioPharma's 5-year Retained Earnings high stood at -$398.1 million for Q2 2022, and its period low was -$493.7 million during Q3 2025.
- Over the past 5 years, Mereo BioPharma's median Retained Earnings value was -$434.7 million (recorded in 2024), while the average stood at -$439.9 million.
- Its Retained Earnings has fluctuated over the past 5 years, first plummeted by 2376.28% in 2021, then surged by 429.57% in 2022.
- Mereo BioPharma's Retained Earnings (Quarter) stood at -$400.3 million in 2021, then dropped by 1.06% to -$404.6 million in 2022, then decreased by 3.72% to -$419.6 million in 2023, then dropped by 10.31% to -$462.9 million in 2024, then decreased by 6.66% to -$493.7 million in 2025.
- Its Retained Earnings was -$493.7 million in Q3 2025, compared to -$486.6 million in Q2 2025 and -$472.0 million in Q1 2025.